HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Pierre Vabres Selected Research

Pierre Vabres Research Topics

Disease

5	Melanoma (Melanoma, Malignant) 01/2014 - 07/2008
4	Hemangioma (Angioma) 02/2015 - 03/2003
3	Ichthyosis (Xeroderma) 03/2015 - 11/2004
2	Bullous Pemphigoid (Pemphigoid) 01/2015 - 01/2014
2	Anetoderma 05/2010 - 04/2002
1	Hypoglycemia (Reactive Hypoglycemia) 02/2015
1	Body Weight (Weight, Body) 02/2015
1	Bradycardia 02/2015
1	Hypotension (Low Blood Pressure) 02/2015
1	Bronchial Spasm 02/2015
1	Blister (Bulla) 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 03/2014
1	Adenocarcinoma 03/2014
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2014
1	Lymphopenia (Lymphocytopenia) 01/2014
1	Drug Eruptions (Drug Eruption) 03/2013
1	Neoplasms (Cancer) 02/2013
1	Mental Retardation (Idiocy) 11/2012
1	Craniosynostoses (Craniosynostosis) 11/2012
1	Gingivitis 01/2012
1	Malformed Nails (Pachyonychia) 01/2012
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 01/2012
1	Kidney Neoplasms (Kidney Cancer) 12/2011
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2011
1	Anoxia (Hypoxia) 12/2011
1	Warts (Wart) 09/2011
1	Pleural Effusion (Pleural Effusions) 09/2011
1	Ascites 09/2011
1	Colorectal Neoplasms (Colorectal Cancer) 09/2011
1	Epilepsy (Aura) 05/2011
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 05/2011
1	Macrocephaly 05/2011
1	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 05/2011
1	Leiomyoma (Uterine Fibroids) 04/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2011
1	Mycosis Fungoides 06/2008
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2008
1	Hypersensitivity (Allergy) 03/2007
1	Sclerosing Cholangitis 11/2004
1	Multiple Hamartoma Syndrome (Cowden's Disease) 03/2003
1	Epiretinal Membrane (Epiretinal Membranes) 03/2003

Drug/Important Bio-Agent (IBA)

3	Propranolol (Inderal)FDA LinkGeneric 02/2015 - 08/2010
2	Immunologic Factors (Immunomodulators)IBA 01/2014 - 01/2014
2	Dacarbazine (DIC)FDA LinkGeneric 01/2014 - 02/2013
2	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2012 - 07/2008
1	CytokinesIBA 01/2015
1	Interleukin-23 (Interleukin 23)IBA 01/2015
1	AutoantibodiesIBA 01/2015
1	Peptide Hydrolases (Proteases)IBA 01/2015
1	Interleukin-17 (Interleukin 27)IBA 01/2015
1	4-O-carboxymethylascochlorinIBA 03/2014
1	quinoline yellow (D & C Yellow #10)IBA 03/2013
1	LigandsIBA 02/2013
1	Neuraminidase deficiency with beta-galactosidase deficiencyIBA 11/2012
1	Nonsense Codon (Nonsense Mutation)IBA 01/2012
1	Microphthalmia-Associated Transcription FactorIBA 12/2011
1	Carbon MonoxideIBA 12/2011
1	capecitabine (Xeloda)FDA Link 09/2011
1	Glomus vagale tumorsIBA 09/2011
1	Megalencephaly cutis marmorata telangiectatica congenitaIBA 05/2011
1	Cutis marmorata telangiectatica congenitaIBA 05/2011
1	hereditary Leiomyomatosis and renal cell cancerIBA 04/2011
1	Keratins (Keratin)IBA 10/2010
1	Proteins (Proteins, Gene)IBA 07/2008
1	Cell Cycle ProteinsIBA 07/2008
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 07/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2008
1	pegylated liposomal doxorubicinIBA 06/2008
1	PlatinumIBA 03/2007
1	SaltsIBA 03/2007
1	claudin 1 (CLDN1)IBA 11/2004
1	Retinaldehyde (Retinal)IBA 03/2003
1	Metalloproteases (Metalloproteinases)IBA 04/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2014 - 03/2007
1	Skin Care 03/2015
1	Neonatal Intensive Care 05/2010
1	Ligation 07/2008
1	Vitrectomy 03/2003